Psycho-Babble Medication | about biological treatments | Framed
This thread | Show all | Post follow-up | Start new thread | List of forums | Search | FAQ

Re: Is this good?

Posted by SLS on December 8, 2006, at 9:18:27

In reply to Re: Is this good?, posted by TrishP on December 8, 2006, at 8:35:57

> That's about it. I haven't tried Keppra. Is it a mono-therapy drug or is it something that I would add to the Abilify? I wonder if it has weight gain issues.


What benefit are you receiving from Abilify?

Take a look at this abstract regarding Keppra (levetiracetam). It describes a case that ended up responding to Keppra monotherapy after years of experimentation with polypharmacy. The dosages used with this patient were approximately 2000mg. When I tried Keppra, I did not gain any weight from it.


- Scott


----------------------------------------------

1: Epilepsy Behav. 2004 Dec;5(6):1017-20.Click here to read Links
Monotherapy treatment of bipolar disorder with levetiracetam.

* Kaufman KR.

Department of Psychiatry, UMDNJ-Robert Wood Johnson Medical School, 125 Paterson Street, Suite 2200, New Brunswick, NJ 08901, USA. kaufmakr@umdnj.edu

Bipolar patients with early-onset, comorbid substance abuse, rapid cycling, and mixed episodes are difficult to treat and frequently require rational polypharmacy. When polypharmacy is unsuccessful, the clinician must consider the off-label use of newer psychotropics. Levetiracetam is a novel anticonvulsant with antikindling, inhibitory, and neuroprotective properties that is effective in an animal model of mania. This case report describes a patient with treatment-resistant rapid cycling bipolar disorder who failed 15 psychotropics, individually or in various combinations (maximum of 6), but ultimately responded to levetiracetam monotherapy and remained without bipolar features during 1 year of maintenance treatment, excluding 1 week during which the patient was medicine noncompliant. Further, methylphenidate used to treat comorbid attention deficit disorder did not precipitate manic features. Levetiracetam should be further studied for its potential use in the treatment of bipolar disorders.

PMID: 15582854 [PubMed - indexed for MEDLINE]

 

Thread

 

Post a new follow-up

Your message only Include above post


Notify the administrators

They will then review this post with the posting guidelines in mind.

To contact them about something other than this post, please use this form instead.

 

Start a new thread

 
Google
dr-bob.org www
Search options and examples
[amazon] for
in

This thread | Show all | Post follow-up | Start new thread | FAQ
Psycho-Babble Medication | Framed

poster:SLS thread:711188
URL: http://www.dr-bob.org/babble/20061206/msgs/711442.html